Search results
Results from the WOW.Com Content Network
Martin Shkreli (/ ˈ ʃ k r ɛ l i /; born March 17, 1983) is an American investor and businessman.Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare, the co-founder and former CEO of pharmaceutical firms Retrophin and Turing Pharmaceuticals, and the former CEO of start-up software company Gödel Systems, which he founded in August 2016.
Joanna Smith-Griffin is the latest Forbes 30 Under 30 alum facing criminal charges, joining Sam Bankman-Fried, Charlie Javice, and Martin Shkreli.
NEW YORK (Reuters) -Martin Shkreli, known for once hiking the price of a life-saving drug more than 4,000%, cannot return to the pharmaceutical industry after a federal appeals court on Tuesday ...
The U.S. Supreme Court declined on Monday to hear former pharmaceutical company CEO Martin Shkreli's challenge to a $64.6 million financial penalty imposed by a judge after he raised a lifesaving ...
Martin Shkreli, the convicted fraudster and sometime "Pharma Bro" turned medical AI entrepreneur, is also a supporter. E/Acc represents a growing sectarian split within the still relatively young ...
Martin Shkreli: 87850-053: Released May 18, 2022 after serving four years, two months [13] Nicknamed the "pharma bro." Convicted of securities fraud. Was originally at Fort Dix, until it was discovered he was still running his company via a contraband cellphone, which led to his transfer to Allenwood. Tal Prihar: 12911-509
NEW YORK, March 5 (Reuters) - Former drug company executive Martin Shkreli may have to give up a Picasso and a one-of-a-kind Wu-Tang Clan album, after a U.S. judge on Monday ordered him to forfeit ...
Martin Shkreli, the pharmaceutical entrepreneur serving a seven-year prison term for fraud, has settled all outstanding disputes with Retrophin Inc, the biopharmaceutical company he founded in ...